POOLED MUTANT KRAS-TARGETED LONG PEPTIDE VACCINE COMBINED WITH ANTI-PD-1 AND ANTI-CTLA-4 ANTIBODIES FOR PATIENTS WITH STAGE IV MMR-P PANCREATIC DUCTAL ADENOCARCINOMA
$835,531FY2024Defense Health AgencyDOD
The Johns Hopkins University
The Johns Hopkins University